# ENZEEVU

NDC: 61314-504
Generic name: aflibercept
Labeler / Manufacturer: Sandoz Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: INTRAVITREAL
Marketing started: 20261026

FDA application: BLA761382

## Active ingredients

- AFLIBERCEPT: 2 mg/.05mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"61314-504"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=61314-504